• All
  • 2013
  • 2015
  • 2016
  • 2017

LabKey Announces Newest Member of Panorama Partners Program

LabKey Announces Newest Member of Panorama Partners Program National Cancer Institute (NCI) Clinical Proteomic Tumor Analysis Consortium (CPTAC) has become the newest member of the Panorama Partners Program SEATTLE, WA  – LabKey is pleased to announce that the National Cancer Institute (NCI) Clinical Proteomic Tumor Analysis Consortium (CPTAC) has become the newest member of the […]

LabKey Releases Software Solution for Accelerating Large Molecule Development

LabKey and collaborator Just Biotherapeutics, Inc. (Just) are excited to announce the initial release of LabKey’s newest software solution, LabKey Biologics. Built in collaboration with Just and designed with input from an advisory council of leading pharma and biotech organizations, LabKey Biologics provides drug research teams tools for biological entity registration, assay data integration, and workflow management through a single, intuitive interface. The solution is unique in this space because of its flexibility to adjust and extend to meet the rapidly evolving needs of biotherapeutic research.

Washington Post: Zika infections last much longer during pregnancy, monkey study shows

LabKey collaborators at the O’Connor Lab (University of Wisconsin—Madison) were featured in a recent Washington Post article, sharing insights from on-going Zika virus research.

Fast Co. Design: How Designers Are Helping HIV Researchers Find A Vaccine

Fast Co. Design has released an article featuring LabKey collaborator Artefact and the recently launched CAVD DataSpace project. The CAVD DataSpace portal is a LabKey Server-based “hypothesis engine” and visualization tool, designed in collaboration with Seattle-based design firm Artefact to facilitate open science and collaborative research.

NPR: Scientists Report In Real Time On Challenging Zika Research

LabKey collaborators at the O’Connor Lab (University of Wisconsin-Madison) were recently featured on NPR, sharing details about their current work researching the Zika virus and decision to share research data with the public in real-time.

JAMA Pediatrics: Real-Time Sharing of Zika Virus Data in an Interconnected World

JAMA Pediatrics has released an article authored by LabKey collaborator Dave O’Connor highlighting “Real-Time Sharing of Zika Virus Data in an Interconnected World.” In the piece, O’Connor shares about the development of the Zika experimental science team (ZEST) and the evolution of Zika virus open-data sharing. “As Zika virus reemerged in 2015, an internal HipChat (https://www.hipchat.com/) group […]

Genomics England Selects LabKey for Integrated Data Management Solution

Genomics England has chosen the LabKey Server open source platform to provide its integrated data management solution. Genomics England will work with LabKey to design and develop a solution that will integrate and securely share complex clinical and genomic data for the 100,000 Genomes Project.

LabKey Software Partners with Just Biotherapeutics, Inc.

LabKey Software and Just Biotherapeutics, Inc. have signed a multi-year agreement to develop a new software product that helps biotechnology R&D teams produce more effective and affordable biotherapeutics by optimizing development processes.

LabKey Software Names Michael Gersch as CEO

Seattle business leader Michael Gersch has joined LabKey Software as its new chief executive officer. LabKey Software is a fast-growing open-source software company that offers solutions to help scientists integrate, analyze, and share biomedical research data.

Hutch News covers debut of HICOR IQ

A new article in the Fred Hutch News, Easing cancer’s heavy financial burden, covers both the Hutch Institute for Outcomes Research (HICOR) 2015 Value in Cancer Care (VCC) Summit and the debut of HICOR IQ.

GeekWire: Fred Hutchinson Cancer Research Center offers easy access to data with new ‘Argos’ tool

GeekWire article featuring Argos, a tool developed by LabKey in collaboration with the Hutch.

New England Journal of Medicine highlights TrialShare

We congratulate the Immune Tolerance Network (ITN) on ITN TrialShare’s debut in the New England Journal of Medicine (NEJM). TrialShare has received recognition for how it provides public, interactive access to de-identified data, analyses and figures for published clinical trials.